Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,157.87
1,159.59
1,017.53
1,024.03
1,055.55
1,010.41
1,033.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,157.87
1,159.59
1,017.53
1,024.03
1,055.55
1,010.41
1,033.09
Raw Material Cost
586.91
611.26
552.63
547.90
623.85
564.60
505.67
Purchase of Finished goods
62.93
60.29
56.71
21.08
19.49
30.27
90.86
(Increase) / Decrease In Stocks
10.63
7.04
-16.77
12.94
-4.25
7.52
-0.57
Employee Cost
199.03
189.38
189.27
176.14
183.90
175.60
180.10
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
-0.01
-0.01
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
146.66
144.77
141.23
137.00
138.64
111.06
135.85
Total Expenditure (Excl Depreciation)
1,006.15
1,012.73
923.06
895.06
961.63
889.05
911.90
Operating Profit (PBDIT) excl Other Income
151.72
146.86
94.47
128.97
93.92
121.36
121.19
Other Income
35.30
34.33
32.37
26.73
17.55
14.56
13.47
Operating Profit (PBDIT)
187.02
181.19
126.84
155.70
111.47
135.92
134.66
Interest
23.89
23.74
23.30
23.14
4.54
5.13
11.90
Exceptional Items
-1.80
-18.23
0.00
0.00
8.22
4.78
3.70
Gross Profit (PBDT)
161.33
139.22
103.54
132.56
115.15
135.57
126.46
Depreciation
40.12
39.65
37.86
36.92
40.00
44.52
34.87
Profit Before Tax
121.22
99.57
65.67
95.65
75.14
91.05
91.59
Tax
39.87
31.89
22.98
30.96
-74.47
24.74
24.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
81.34
67.67
42.70
64.69
149.61
66.31
66.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
81.34
67.67
42.70
64.69
149.61
66.31
66.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.27
1.36
1.91
1.21
1.99
1.13
1.45
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
84.61
66.32
40.78
63.48
147.62
65.18
65.21
Equity Capital
30.62
30.62
30.62
30.62
30.62
30.62
30.62
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
2,802.87
Earnings per share (EPS)
5.53
4.33
2.66
4.15
9.64
4.26
4.26
Diluted Earnings per share
5.53
4.33
2.66
4.15
9.64
4.26
4.37
Operating Profit Margin (Excl OI)
13.1%
12.66%
9.28%
12.59%
8.9%
12.01%
11.73%
Gross Profit Margin
13.93%
12.01%
10.18%
12.94%
10.91%
13.42%
12.24%
PAT Margin
7.02%
5.84%
4.2%
6.32%
14.17%
6.56%
6.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is -0.15% vs 13.96% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 27.58% vs 62.63% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 3.31% vs 55.46% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 0.63% vs 1.89% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Akums Drugs With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
1,157.87
409.73
748.14
182.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,157.87
409.73
748.14
182.59%
Raw Material Cost
586.91
100.75
486.16
482.54%
Purchase of Finished goods
62.93
7.14
55.79
781.37%
(Increase) / Decrease In Stocks
10.63
25.43
-14.80
-58.20%
Employee Cost
199.03
83.45
115.58
138.50%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
146.66
78.66
68.00
86.45%
Total Expenditure (Excl Depreciation)
1,006.15
295.43
710.72
240.57%
Operating Profit (PBDIT) excl Other Income
151.72
114.30
37.42
32.74%
Other Income
35.30
0.81
34.49
4,258.02%
Operating Profit (PBDIT)
187.02
115.11
71.91
62.47%
Interest
23.89
10.68
13.21
123.69%
Exceptional Items
-1.80
-12.86
11.06
86.00%
Gross Profit (PBDT)
161.33
91.57
69.76
76.18%
Depreciation
40.12
30.36
9.76
32.15%
Profit Before Tax
121.22
60.85
60.37
99.21%
Tax
39.87
16.27
23.60
145.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
81.34
44.93
36.41
81.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
81.34
44.93
36.41
81.04%
Share in Profit of Associates
0.00
-0.35
0.35
100.00%
Minority Interest
-3.27
0.00
-3.27
Other related items
0.00
0.00
0.00
Consolidated Net Profit
84.61
44.58
40.03
89.79%
Equity Capital
30.62
19.56
11.06
56.54%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
5.53
2.28
3.25
142.54%
Diluted Earnings per share
5.53
2.36
3.17
134.32%
Operating Profit Margin (Excl OI)
13.10%
27.90%
0.00
-14.80%
Gross Profit Margin
13.93%
22.35%
0.00
-8.42%
PAT Margin
7.02%
10.88%
0.00
-3.86%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,157.87 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -0.15% vs 13.96% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 9.69% vs 11.79% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 84.61 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 27.58% vs 62.63% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -42.68% vs 457.26% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 151.72 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 3.31% vs 55.46% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 61.54% vs 3,041.14% in Mar 2025
Quarterly - Interest
Interest 23.89 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 0.63% vs 1.89% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 426.21% vs -63.33% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.10%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
